Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Psychiatry

Prediction of cognitive and metabolic changes after acute antidopaminergic treatment measured by FDOPA PET

Ingo Vernaleken, Yoshitaka Kumakura, Hans-Georg Buchholz, Thomas Siessmeier, Peter Bartenstein, Paul Cumming and Gerhard Gründer
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 263P;
Ingo Vernaleken
1Department of Psychiatry, RWTH Aachen University, Aachen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshitaka Kumakura
2University of Tokyo, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Georg Buchholz
3University of Mainz, Mainz, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Siessmeier
3University of Mainz, Mainz, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
4Ludwig Maximilian Universität, München, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Cumming
5Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Gründer
1Department of Psychiatry, RWTH Aachen University, Aachen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 48 no. supplement 2 263P

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online October 31, 2014.

Copyright & Usage 
Society of Nuclear Medicine, Inc.

Author Information

  1. Ingo Vernaleken1,
  2. Yoshitaka Kumakura2,
  3. Hans-Georg Buchholz3,
  4. Thomas Siessmeier3,
  5. Peter Bartenstein4,
  6. Paul Cumming5 and
  7. Gerhard Gründer1
  1. 1Department of Psychiatry, RWTH Aachen University, Aachen, Germany;
  2. 2University of Tokyo, Tokyo, Japan;
  3. 3University of Mainz, Mainz, Germany;
  4. 4Ludwig Maximilian Universität, München, Germany;
  5. 5Aarhus University, Aarhus, Denmark

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014900
Jan 2015200
Jun 2015100
Jul 2015100
Aug 2015200
Sep 2015400
Jun 2016100
Aug 2016100
Dec 2016100
Jan 2017200
Mar 2017500
Apr 2017200
May 20171500
Jun 2017300
Jul 2017200
Aug 2017100
Sep 2017200
Oct 2017200
Dec 2017100
May 2018100
Jun 2018100
Sep 2020100
Dec 2020300
Feb 2021800
Mar 20212000
Apr 20213100
May 20211600
Jun 2021900
Jul 2021600
Aug 2021500
Sep 2021100
Oct 2021200
Nov 2021300
Dec 2021300
Jan 2022200
Feb 2022200
Mar 2022400
Apr 2022100
May 2022400
Jun 2022200
Aug 2022100
Oct 2022100
Dec 2022100
Jan 2023100
Feb 2023100
Mar 2023100
Apr 2023200
May 2023300
Jun 2023200
Jul 2023100
Aug 2023300
Sep 2023100
Oct 2023300
Nov 2023200
Dec 2023200
Jan 2024300
Feb 2024200
Mar 2024200
May 2024700
Jun 2024100
Aug 2024500
Sep 2024800
Oct 2024400
Nov 2024300
Dec 2024400
Jan 2025200
Mar 2025100
Apr 2025300
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prediction of cognitive and metabolic changes after acute antidopaminergic treatment measured by FDOPA PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prediction of cognitive and metabolic changes after acute antidopaminergic treatment measured by FDOPA PET
Ingo Vernaleken, Yoshitaka Kumakura, Hans-Georg Buchholz, Thomas Siessmeier, Peter Bartenstein, Paul Cumming, Gerhard Gründer
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 263P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prediction of cognitive and metabolic changes after acute antidopaminergic treatment measured by FDOPA PET
Ingo Vernaleken, Yoshitaka Kumakura, Hans-Georg Buchholz, Thomas Siessmeier, Peter Bartenstein, Paul Cumming, Gerhard Gründer
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 263P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Psychiatry

  • Serotonin and dopamine transporter availabilities in brain of depressed patients
  • Differences in dopamine release in Tourette's syndrome and obsessive-compulsive disorder
  • Effects of trigeminal nerve stimulation on regional brain activity in depression
Show more Neurosciences: Psychiatry

Psychiatry Posters

  • Analysis of correlation between brain perfusion and suicidal ideation among patients with major depressive disorder
  • Towards characterizing the regional cerebral perfusion in evaluating the severity of major depression disorder by SPECT/CT
  • A pilot PET/MR study of hippocampal, diffusivity and brain metabolism changes following electroconvulsive therapy
Show more Psychiatry Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire